SIRT1 increases with exercise and is an NAD-dependant deacetylase that protects against NAFLD by inhibiting NF-κB and CD36 thus decreasing hepatic inflammation and steatosis (Niu et al., 2018[107]). Here, CD36 is linked to metabolic dysfunction-associated steatotic liver disease.